Aminoglutethimide

CAS No. 125-84-8

Aminoglutethimide( DL-Aminoglutethimide | NSC 330915 )

Catalog No. M11066 CAS No. 125-84-8

Aminoglutethimide is an aromatase inhibitor that is used in the treatment of advanced BREAST Y.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 49 In Stock
50MG 74 In Stock
100MG 128 In Stock
200MG 163 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aminoglutethimide
  • Note
    Research use only, not for human use.
  • Brief Description
    Aminoglutethimide is an aromatase inhibitor that is used in the treatment of advanced BREAST Y.
  • Description
    Aminoglutethimide is an aromatase inhibitor that is used in the treatment of advanced BREAST Y.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DL-Aminoglutethimide | NSC 330915
  • Pathway
    Endocrinology/Hormones
  • Target
    Aromatase
  • Recptor
    Aromatase
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    125-84-8
  • Formula Weight
    232.28
  • Molecular Formula
    C13H16N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 7 mg/mL (30.13 mM); DMSO: 20 mg/mL (86.1 mM)
  • SMILES
    O=C(C(CC)(C1=CC=C(N)C=C1)CC2)NC2=O
  • Chemical Name
    3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Neves MA, et al. Eur J Med Chem, 2009, 44(10), 4121-4127.
molnova catalog
related products
  • Anastrozole

    Anastrozole(ZD1033) is a potent and highly selective aromatase (CYP19) inhibitor (IC50 = 15 nM) .

  • Testolactone

    Testolactone is an aromatase inhibitor, blocks conversion of androgens to estrogens.It is progesterone derivative with antineoplastic activity.?

  • Flavokawain A

    Flavokawain A has anti-tumor activity, such as inhibits growth of bladder tumor cells in a nude mice model , prevents the recurrence and progression of non-muscle-invasive urothelial cell carcinoma.